Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorogenic acid is a natural polyphenol compound, specifically the ester of caffeic acid and quinic acid, found abundantly in coffee beans and various plants. It is known for its antioxidant, anti-inflammatory, and potential chemopreventive properties. Chlorogenic acid has been investigated for its effects on cardiovascular health, blood glucose regulation (anti-diabetic effect), weight management (anti-obesity effect), and as a possible adjunct in cancer therapy. Mechanistically, it acts by inhibiting inflammatory pathways such as NF-κB signaling and modulating TLR4/MyD88 axis activity, leading to reduced production of pro-inflammatory mediators like TNF-α, NO, COX-2, and PGE2[3][6][8]. It has not been approved as a prescription drug or food additive but is widely used as a dietary supplement[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorogenic acid.